Phase I Study of an Oxaliplatin-Etoposide Regimen in Pediatric Patients with Recurrent Solid Tumors

BACKGROUND: The combination of a platinating agent and etoposide has induced responses in various pediatric tumors. This study estimates the maximum tolerated dose (MTD) of an oxaliplatin and etoposide regimen in children with recurrent solid tumors. METHODS: Oxaliplatin was administered on day 1 an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McGregor, Lisa M., Spunt, Sheri L., Santana, Victor M., Stewart, Clinton F., Ward, Deborah A., Watkins, Amy, Laningham, Fred H., Ivy, Percy, Furman, Wayne L., Fouladi, Maryam
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852396/
https://ncbi.nlm.nih.gov/pubmed/19117350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24054
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados